PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, 17020, Turkey. emre.saygili@comu.edu.tr.\', \'Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, 17020, Turkey.\', \'Department of Internal Medicine, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey.\', \'Department of Infections Disease, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey.\', \'Department of Pulmonary Disease, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11845-021-02823-9
?:doi
?:hasPublicationType
?:journal
  • Irish journal of medical science
is ?:pmid of
?:pmid
?:pmid
  • 34713419
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.354
?:rankingScore_hIndex
  • 27
is ?:relation_isRelatedTo_publication of
?:title
  • Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all